Y-mAbs Therapeutics, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
YMAB on Nasdaq
Industry
Pharmaceutical Preparations
Location
202 Carnegie Center, Suite 301, Princeton, NJ

Insiders trading volume in the past year

Y-mAbs Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bo Kruse Evp, Cfo, Secry & Treas. $2.55M May 30, 2024
Torben Lund-Hansen Svp & Chief Technical Officer $1.25M Aug 28, 2024
Vignesh Rajah Svp & Chief Medical Officer $631K Mar 5, 2024
Susan Laura Smith Svp & Chief Commercial Officer $561K Mar 5, 2024
Mary Tagliaferri Director $97.9K Jun 11, 2024
Steen Lisby Svp & Chief Scientific Officer $71.2K Jan 18, 2024
Gerard Ber Director $19.3K Jun 10, 2024
Laura Hamill Director $0 Sep 16, 2025
John LaRocca SVP, General Counsel & Secry $0 Sep 16, 2025
David N. Gill Director $0 Sep 16, 2025
Peter P. Pfreundschuh EVP, CFO and Treasurer $0 Sep 16, 2025
Joris Wilms Svp & Chief Operating Officer $0 Sep 16, 2025
Thomas Gad CHIEF BUSINESS OFFICER, Director $0 -$56.5K -100% Sep 16, 2025
Ashu Tyagi Director $0 Sep 16, 2025
WG Biotech ApS Director, 10%+ Owner $0 Sep 16, 2025
James Healy Director $0 Sep 16, 2025
Johan Wedell-Wedellsborg Director, 10%+ Owner $0 Sep 16, 2025
Michael J. Rossi PRESIDENT & CEO, Director $0 -$20.4K -100% Sep 16, 2025
Douglas J. Gentilcore SVP, Danyelza Bus. Unit Head Sep 16, 2025
Moller-San Pedro Claus Juan Director and CEO, Director Dec 14, 2021

Recent Insider Transactions by Companies or Individuals for Y-mAbs Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.